The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1293
Zingo for Local Analgesia in Children
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

The FDA has approved the marketing of a new device for delivering lidocaine to the skin of children undergoing a venipuncture or intravenous (IV) line placement. Zingo (Anesiva) is a powder intradermal injection system.

THE DEVICE — The Zingo device is a cylinder 6.5 inches long that resembles a small flashlight. When the flat end is pressed against the skin, a “start” button near the top of the cylinder is unlocked. Pressing the button slices off the tip of an inner cylinder containing pressurized helium gas. With an audible “pop”, the released gas propels 0.5 mg of lidocaine powder into an area of skin 2 cm in diameter. Each device can only be used once, at a cost of $20, according to the manufacturer.

CLINICAL STUDIES — Two studies of this lidocaine powder delivery system have been published. One in 306 children and adolescents undergoing venipuncture for drawing blood ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Zingo for Local Analgesia in Children
Article code: 1293d
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian